ReviewACS omega2026
Microbial-Based Agrochemicals: Cell-in and Cell-free Formulations, Application, and Production via Agricultural Byproducts for a Circular Economy.
Review in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Modern agriculture relies on synthetic agrochemicals, but regulatory pressure, environmental costs, and supply chain volatility are accelerating interest in microbial-based agrochemicals (MBAs) as renewable inputs for sustainable intensification. This review frames MBAs through a circular economy lens, highlighting agricultural byproducts as fermentation feedstocks and formulation carriers to reduce cost and footprint while enabling scale-up. We compare cell-in products, which require viable microorganisms to survive processing, storage, and field stresses and to establish in target niches, versus cell-free products, which depend on maintaining the activity and residence time of metabolites, enzymes, and extracts despite degradation, dilution, and adsorption. We summarize submerged and solid-state fermentation and downstream routes to biomass or clarified bioactive fractions and link formulation families (liquids, solids, granules, encapsulated/controlled-release, immobilized) to delivery routes (seed, soil, foliar, fertigation). We highlight critical quality attributes, release criteria, and validation metrics connecting process control to field performance, then outline barriers (feedstock heterogeneity, batch variability, compatibility, context dependence) and priorities for standardization, mechanism-based stabilization/controlled release, and multienvironment validation.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.